(October 26, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Board of Directors has authorized the repurchase of up to 50 million shares of the Company's common stock from time to time at prevailing market prices. Repurchased shares will be made available for issuance under the Company's equity incentive plans and for general corporate purposes, including acquisitions and strategic alliances.

The shares will be repurchased on the open market or in privately negotiated transactions at the Company's discretion, in accordance with applicable laws and subject to market conditions and other factors, including black-out periods during which the Company may be prohibited from trading in the Company